- Home
- ZDGE vs RVPH Comparison
ZDGE vs RVPH Comparison
Compare ZDGE & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- RVPH
- Stock Information
- Founded
- ZDGE 2008
- RVPH 2006
- Country
- ZDGE United States
- RVPH United States
- Employees
- ZDGE N/A
- RVPH N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- RVPH Health Care
- Exchange
- ZDGE Nasdaq
- RVPH Nasdaq
- Market Cap
- ZDGE 40.3M
- RVPH 36.7M
- IPO Year
- ZDGE N/A
- RVPH N/A
- Fundamental
- Price
- ZDGE $2.57
- RVPH $0.81
- Analyst Decision
- ZDGE
- RVPH Strong Buy
- Analyst Count
- ZDGE 0
- RVPH 5
- Target Price
- ZDGE N/A
- RVPH $9.00
- AVG Volume (30 Days)
- ZDGE 28.4K
- RVPH 600.3K
- Earning Date
- ZDGE 06-12-2025
- RVPH 05-15-2025
- Dividend Yield
- ZDGE N/A
- RVPH N/A
- EPS Growth
- ZDGE N/A
- RVPH N/A
- EPS
- ZDGE N/A
- RVPH N/A
- Revenue
- ZDGE $29,412,000.00
- RVPH N/A
- Revenue This Year
- ZDGE N/A
- RVPH N/A
- Revenue Next Year
- ZDGE $1.07
- RVPH N/A
- P/E Ratio
- ZDGE N/A
- RVPH N/A
- Revenue Growth
- ZDGE 4.26
- RVPH N/A
- 52 Week Low
- ZDGE $1.73
- RVPH $0.49
- 52 Week High
- ZDGE $4.38
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- ZDGE 58.42
- RVPH 44.29
- Support Level
- ZDGE $2.29
- RVPH $0.78
- Resistance Level
- ZDGE $2.47
- RVPH $1.15
- Average True Range (ATR)
- ZDGE 0.11
- RVPH 0.10
- MACD
- ZDGE 0.01
- RVPH -0.02
- Stochastic Oscillator
- ZDGE 98.03
- RVPH 9.37
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.